Legal & General Group’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.6K | Sell |
2,502
-22,620
| -90% | -$294K | ﹤0.01% | 2823 |
|
|
2025
Q1 | $266K | Buy |
25,122
+975
| +4% | +$10.3K | ﹤0.01% | 2569 |
|
|
2024
Q4 | $410K | Hold |
24,147
| – | – | ﹤0.01% | 2531 |
|
|
2024
Q3 | $560K | Buy |
24,147
+823
| +4% | +$19.1K | ﹤0.01% | 2426 |
|
|
2024
Q2 | $568K | Buy |
23,324
+1,579
| +7% | +$38.4K | ﹤0.01% | 2380 |
|
|
2024
Q1 | $734K | Buy |
21,745
+732
| +3% | +$24.7K | ﹤0.01% | 2292 |
|
|
2023
Q4 | $663K | Buy |
21,013
+681
| +3% | +$21.5K | ﹤0.01% | 2353 |
|
|
2023
Q3 | $519K | Sell |
20,332
-28
| -0.1% | -$715 | ﹤0.01% | 2419 |
|
|
2023
Q2 | $584K | Buy |
20,360
+10,500
| +106% | +$301K | ﹤0.01% | 2413 |
|
|
2023
Q1 | $236K | Buy |
9,860
+484
| +5% | +$11.6K | ﹤0.01% | 2526 |
|
|
2022
Q4 | $159K | Buy |
9,376
+515
| +6% | +$8.73K | ﹤0.01% | 2695 |
|
|
2022
Q3 | $131K | Sell |
8,861
-5,010
| -36% | -$74.1K | ﹤0.01% | 2748 |
|
|
2022
Q2 | $218K | Buy |
13,871
+1,305
| +10% | +$20.5K | ﹤0.01% | 2594 |
|
|
2022
Q1 | $339K | Hold |
12,566
| – | – | ﹤0.01% | 2500 |
|
|
2021
Q4 | $465K | Buy |
12,566
+2,985
| +31% | +$110K | ﹤0.01% | 2437 |
|
|
2021
Q3 | $457K | Buy |
9,581
+4,155
| +77% | +$198K | ﹤0.01% | 2438 |
|
|
2021
Q2 | $184K | Sell |
5,426
-556
| -9% | -$18.9K | ﹤0.01% | 2553 |
|
|
2021
Q1 | $247K | Sell |
5,982
-63
| -1% | -$2.6K | ﹤0.01% | 2418 |
|
|
2020
Q4 | $262K | Buy |
6,045
+688
| +13% | +$29.8K | ﹤0.01% | 2369 |
|
|
2020
Q3 | $229K | Sell |
5,357
-234
| -4% | -$10K | ﹤0.01% | 2333 |
|
|
2020
Q2 | $262K | Buy |
+5,591
| New | +$262K | ﹤0.01% | 2305 |
|